GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sanofi Consumer Healthcare India Ltd (BOM:544250) » Definitions » Operating Income

Sanofi Consumer Healthcare India (BOM:544250) Operating Income : ₹1,848 Mil (TTM As of Mar. 2025)


View and export this data going back to 2024. Start your Free Trial

What is Sanofi Consumer Healthcare India Operating Income?

Sanofi Consumer Healthcare India's Operating Income for the three months ended in Mar. 2025 was ₹620 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Mar. 2025 was ₹1,848 Mil.

Operating Margin % is calculated as Operating Income divided by its Revenue. Sanofi Consumer Healthcare India's Operating Income for the three months ended in Mar. 2025 was ₹620 Mil. Sanofi Consumer Healthcare India's Revenue for the three months ended in Mar. 2025 was ₹1,726 Mil. Therefore, Sanofi Consumer Healthcare India's Operating Margin % for the quarter that ended in Mar. 2025 was 35.92%.

Sanofi Consumer Healthcare India's 5-Year average Growth Rate for Operating Margin % was 0.00% per year.

Operating Income or EBIT is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Sanofi Consumer Healthcare India's annualized ROC % for the quarter that ended in Mar. 2025 was 206.94%. Sanofi Consumer Healthcare India's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2025 was 963.44%.


Sanofi Consumer Healthcare India Operating Income Historical Data

The historical data trend for Sanofi Consumer Healthcare India's Operating Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sanofi Consumer Healthcare India Operating Income Chart

Sanofi Consumer Healthcare India Annual Data
Trend Dec23 Dec24
Operating Income
2,172.00 2,662.00

Sanofi Consumer Healthcare India Quarterly Data
Sep23 Dec23 Mar24 Sep24 Dec24 Mar25
Operating Income Get a 7-Day Free Trial 890.00 809.00 616.00 612.00 620.00

Sanofi Consumer Healthcare India Operating Income Calculation

Operating Income, is the profit a company earned through operations. All expenses, including cash expenses such as cost of goods sold (COGS), research & development, wages, and non-cash expenses, such as depreciation, depletion and amortization, have been deducted from the sales.

Operating Income for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹1,848 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sanofi Consumer Healthcare India  (BOM:544250) Operating Income Explanation

1. Operating Income or EBIT is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Sanofi Consumer Healthcare India's annualized ROC % for the quarter that ended in Mar. 2025 is calculated as:

ROC % (Q: Mar. 2025 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2024 ) + Invested Capital (Q: Mar. 2025 ))/ count )
=2480 * ( 1 - 25.15% )/( (897 + 0)/ 1 )
=1856.28/897
=206.94 %

where

Note: The Operating Income data used here is four times the quarterly (Mar. 2025) data.

2. Joel Greenblatt's definition of Return on Capital:

Sanofi Consumer Healthcare India's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2025 is calculated as:

ROC (Joel Greenblatt) %(Q: Mar. 2025 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2024  Q: Mar. 2025
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=2688/( ( (279 + max(-665, 0)) + (0 + max(0, 0)) )/ 1 )
=2688/( ( 279 + 0 )/ 1 )
=2688/279
=963.44 %

where Working Capital is:

Working Capital(Q: Dec. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(137 + 409 + 58) - (805 + 0 + 464)
=-665

Working Capital(Q: Mar. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0 + 0 + 0) - (0 + 0 + 0)
=0

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Mar. 2025) EBIT data.

3. Operating Income is also linked to Operating Margin %:

Sanofi Consumer Healthcare India's Operating Margin % for the quarter that ended in Mar. 2025 is calculated as:

Operating Margin %=Operating Income (Q: Mar. 2025 )/Revenue (Q: Mar. 2025 )
=620/1726
=35.92 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

4. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Operating Income growth rate using Operating Income per share data.


Be Aware

Compared with a company's EBITDA margin, Operating Margin can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin may decline. Often the Operating Margin declines well before the company's revenue or even profit decline. Therefore, Operating Margin is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia's Operating Margin had already been in decline since 2002, although its earnings per share were still rising. Investors who paid attention to Operating Margin would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.


Sanofi Consumer Healthcare India Operating Income Related Terms

Thank you for viewing the detailed overview of Sanofi Consumer Healthcare India's Operating Income provided by GuruFocus.com. Please click on the following links to see related term pages.


Sanofi Consumer Healthcare India Business Description

Traded in Other Exchanges
Address
Saki Vihar Road, L&T business park, 3rd Floor, Sanofi House, CTS No. 117-B, Powai, Mumbai, MH, IND, 400072
Sanofi Consumer Healthcare India Ltd is engaged in the business of manufacturing, producing, processing, marketing, formulating, buying, trading, storing, packing, selling, distributing, importing, exporting, providing consultancy and otherwise dealing in all varieties of pharmaceuticals especially consumer healthcare products.

Sanofi Consumer Healthcare India Headlines

No Headlines